Dr. Shweta Patel, DO

Dr. Patel practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Patel's NPI, 1831464965, was assigned on March 22, 2012. Dr. Patel holds Pennsylvania license OS016380.

Dr. Patel's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Patel's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Patel is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Patel to 4 more hospitals and 1 medical group, each named with a free account. Dr. Patel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 6 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Patel is licensed in Pennsylvania.

CMS data shows 1,577 Medicare services from Dr. Patel across 17 procedure codes in 2024, for 656 Medicare patients. Medicare paid $45,387 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 656 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 333 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 52, with 47% women.

In 2023, Dr. Patel wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $62 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 2 general payments to Dr. Patel from 2 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $22.